Selank Peptide: Complete Guide

Selank is a synthetic peptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It’s a modified analog of tuftsin, a naturally occurring immune-regulating tetrapeptide, with a Pro-Gly-Pro tripeptide added to its C-terminus to extend its biological half-life [1].

What makes Selank unusual in the peptide therapy world is its dual action: it functions as both an anxiolytic (anxiety-reducing) and a nootropic (cognition-enhancing) compound. It’s approved in Russia as a prescription drug for generalized anxiety disorder, and research suggests it works through GABAergic modulation and neurotrophic factor upregulation rather than the sedation pathways used by benzodiazepines [2][3].

Selank is often discussed alongside Semax, its sibling peptide from the same research institute. Both are Russian-developed neuropeptides, but they work through different mechanisms and serve different primary purposes. For a broader look at cognitive peptides, see our guide on peptides for cognitive function.

Key Takeaways

Selank is a synthetic analog of tuftsin with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, developed for anxiety and cognitive support
It modulates the GABAergic system without causing sedation or dependence — a significant advantage over benzodiazepines
Approved in Russia since 2009 as a nasal spray for anxiety disorders; not FDA-approved in the U.S.
Typical dosing is 200–400 mcg intranasally per day, split into 2–3 administrations

What Is Selank?
How Selank Works
Clinical Evidence
Selank Dosing
Side Effects and Safety
Selank vs Semax
Legal Status
FAQ
Sources

What Is Selank?

Tuftsin is a tetrapeptide (Thr-Lys-Pro-Arg) naturally produced by enzymatic cleavage of IgG antibodies in the spleen. It plays a role in innate immunity, particularly in activating phagocytic cells. Russian researchers observed that tuftsin also appeared to have effects on the central nervous system — specifically on anxiety-related behavior in animal models [1].

The problem with natural tuftsin is that it’s rapidly degraded by enzymes in the blood and brain. Its half-life is measured in minutes. To make it therapeutically useful, the research team at the Institute of Molecular Genetics added a stabilizing Pro-Gly-Pro (PGP) sequence to the C-terminus, creating the heptapeptide Selank (TKPRPGP) [1][4].

This modification accomplished two things: it dramatically extended the peptide’s active life and it altered its pharmacological profile, enhancing the anxiolytic and nootropic properties beyond what tuftsin alone could achieve. The result was a compound that could be administered intranasally and produce measurable effects on anxiety and cognition within 10–15 minutes [4].

Selank was approved by the Russian Ministry of Health in 2009 as a 0.15% nasal spray under the trade name Selanc for the treatment of generalized anxiety disorder (GAD) and neurasthenia [2]. You can find it on our list of peptides alongside other research and approved compounds.

How Selank Works

Selank’s mechanism is multi-layered, touching several neurotransmitter systems simultaneously.

GABA System Modulation

The primary anxiolytic effect appears to come from Selank’s interaction with the GABAergic system. Research published in Frontiers in Pharmacology demonstrated that Selank alters the expression of genes involved in GABA neurotransmission, specifically affecting GABA-A receptor subunit composition [3].

Unlike benzodiazepines, which directly bind to GABA-A receptors and force them open, Selank acts as an allosteric modulator. It changes the receptor’s sensitivity to GABA without directly activating it. This produces anxiolytic effects without the sedation, motor impairment, or dependence risk that comes with direct GABA-A agonism [3][5].

Studies in animal models showed that Selank’s effects on GABA-related gene expression occur rapidly — within hours of administration — and affect both the concentration of GABA in the brain and the enzyme systems that produce and metabolize it [3].

BDNF and Neurotrophic Factors

Selank increases brain-derived neurotrophic factor (BDNF) expression in the hippocampus and prefrontal cortex [6]. BDNF is a protein that supports the survival of existing neurons and encourages the growth of new neurons and synapses. It’s considered one of the most important molecules for learning, memory, and cognitive flexibility.

Research by Kolik et al. (2019) showed that Selank protects against ethanol-induced memory impairment by regulating BDNF content in the hippocampus and prefrontal cortex [6]. This suggests the nootropic effects aren’t just about reducing anxiety — there’s a direct neurotrophic component.

Enkephalin Stabilization

Selank inhibits the enzymes that break down enkephalins, the body’s natural opioid-like peptides involved in pain modulation and mood regulation. By slowing enkephalin degradation, Selank can prolong their mood-stabilizing effects without engaging opioid receptors directly [7]. This may contribute to its reported effects on general well-being and emotional balance. Selank’s mood-stabilizing properties also make it relevant for those exploring peptides for depression.

Immune Modulation

As a tuftsin analog, Selank retains some immunomodulatory properties. It has been shown to influence cytokine expression, with studies reporting changes in IL-6 and other inflammatory markers [1]. This dual neuro-immune activity is relatively rare among neuropeptides and may be relevant for conditions where anxiety and immune dysfunction overlap.

Clinical Evidence

Anxiety Disorders

The clinical data supporting Selank for anxiety comes primarily from Russian clinical trials conducted during its regulatory approval process.

A randomized, double-blind, placebo-controlled trial in patients with generalized anxiety disorder found that Selank nasal spray (0.15%, three drops per nostril, three times daily for 14 days) produced significant reductions in anxiety symptoms as measured by the Hamilton Anxiety Rating Scale (HAM-A). The anxiolytic effect was comparable to medazepam (a benzodiazepine) but without sedation or cognitive impairment [2][8].

The onset of action was rapid, with patients reporting noticeable anxiety reduction within 3–5 days of starting treatment. Effects persisted for at least 1 week after discontinuation, suggesting some sustained neuroplastic change rather than just acute receptor modulation [8].

Cognitive Enhancement

Animal studies have consistently shown that Selank improves performance on learning and memory tasks. Rats treated with Selank showed enhanced spatial memory in Morris water maze tests and improved conditioned avoidance responses [9].

In human studies, Selank improved attention and short-term memory in patients with anxiety-related cognitive complaints. The cognitive benefits appeared to be partly independent of anxiety reduction — patients showed improved information processing even when controlling for mood changes [8].

Neuroprotection

Preclinical research suggests Selank has neuroprotective properties. In models of cerebral ischemia, it reduced neuronal death and inflammatory markers. The BDNF upregulation is likely a key mechanism here, as BDNF promotes neuronal survival under stress conditions [6][10].

Selank Dosing

Standard Protocol (Nasal)

The approved Russian protocol uses Selank as a 0.15% nasal spray solution:

Dose: 200–400 mcg per day
Administration: 2–3 drops per nostril, 2–3 times daily
Duration: 14-day treatment courses, which can be repeated
Onset: Effects typically noticed within 3–5 days; some users report same-day anxiolytic effects

Subcutaneous Protocol

Some practitioners outside Russia prescribe Selank via subcutaneous injection, though this is off-label:

Dose: 250–500 mcg per day
Administration: Once daily SC injection
Duration: Cycles of 10–20 days

The nasal route is preferred by most users for convenience and because it provides more direct access to the CNS through the nasal mucosa. For those unfamiliar with peptide preparation, see our guide on how to reconstitute peptides.

Timing Considerations

Selank is best taken during waking hours since its nootropic effects can increase alertness. Most users split their daily dose between morning and early afternoon. For more on timing strategies, see when to take peptides.

Side Effects and Safety

Selank has demonstrated a strong safety profile across both clinical trials and decades of use in Russia.

Reported side effects are minimal:

Nasal irritation or mild burning sensation (with intranasal use)
Occasional mild headache during the first few days
Rarely, fatigue or drowsiness (paradoxical, given its alerting properties)

What hasn’t been reported:

No sedation or psychomotor impairment (unlike benzodiazepines)
No withdrawal symptoms or dependence after discontinuation
No significant changes in blood pressure, heart rate, or laboratory values
No reports of tolerance development with repeated courses

The absence of dependence potential is one of Selank’s most significant advantages over conventional anxiolytics. Benzodiazepines produce physical dependence within weeks of daily use. Selank does not appear to cause any withdrawal syndrome, even after repeated 14-day courses [2][8].

For a general overview of what to watch for with any peptide, see our guide on peptide side effects. And for safety considerations across the category, see are peptides safe.

Selank vs Semax

Selank and Semax are frequently compared because they share a common origin — both were developed at the same Russian research institute and both are approved prescription drugs in Russia. But they have distinct profiles:

Feature	Selank	Semax
Base molecule	Tuftsin analog	ACTH(4-7) analog
Primary effect	Anxiolytic + nootropic	Cognitive enhancement + neuroprotection
GABA modulation	Strong (primary mechanism)	Minimal
BDNF upregulation	Moderate	Strong
NGF upregulation	Not established	Yes
Anxiety reduction	Primary indication	Secondary benefit
Focus/alertness	Moderate	Strong
Russian approval	GAD, neurasthenia	Stroke, cognitive disorders, optic nerve disease
Typical dose	200–400 mcg/day nasal	200–600 mcg/day nasal

When to choose Selank: If the primary concern is anxiety, stress, or anxiety-related cognitive issues. Selank addresses the emotional component first and the cognitive benefits follow.

When to choose Semax: If the primary goal is cognitive performance, focus, or neuroprotection. Semax is more stimulating and directly targets neurotrophic pathways.

Stacking: Some practitioners use both together, with Selank in the morning/afternoon for anxiety management and Semax for cognitive tasks. This is an off-label approach without specific clinical trial support, but the mechanisms are complementary rather than contradictory. For more on combining peptides, see our best peptide stack guide.

Legal Status

Russia: Approved prescription drug since 2009. Available as a 0.15% nasal spray (Selanc) for GAD and neurasthenia.

United States: Selank is not FDA-approved and is not available as a commercial pharmaceutical product. It may be available through compounding pharmacies with a physician’s prescription, depending on current regulatory status. Check our guide on peptide legality and the 2026 FDA reclassification for the latest information.

Other countries: Not widely approved outside Russia. Available as a research compound in many jurisdictions.

Explore the evidence: See all 8 Selank studies in our research database, or browse the full peptide therapy statistics for 2026.

FAQ

Does Selank really work for anxiety?▼

Russian clinical trials showed statistically significant anxiety reduction comparable to benzodiazepines, without the sedation or dependence. The evidence is real but limited primarily to Russian studies. Large-scale Western clinical trials have not been conducted [2][8]. For a broader look at how peptides address anxiety, see our full guide to peptides for anxiety.

How quickly does Selank work?▼

Most users notice anxiolytic effects within 10–15 minutes of intranasal administration, with full therapeutic effects building over 3–5 days of consistent use. The rapid onset is due to direct absorption through the nasal mucosa into the CNS [4].

Is Selank addictive?▼

No. Unlike benzodiazepines and other GABAergic anxiolytics, Selank has not shown any dependence potential or withdrawal symptoms in clinical studies. Its mechanism of allosteric GABA modulation rather than direct receptor activation is likely why [3][5].

Can I take Selank with other medications?▼

There are limited drug interaction studies for Selank. Because it modulates GABA systems, caution is warranted when combining with benzodiazepines, barbiturates, or other GABAergic drugs. Always discuss combinations with a prescribing physician.

What’s the difference between Selank and prescription anti-anxiety medications?▼

Selank works through GABAergic modulation and BDNF upregulation without directly binding to benzodiazepine receptor sites. This means no sedation, no motor impairment, no dependence, and no withdrawal — all significant advantages. The trade-off is that the anxiolytic effect may be milder than high-dose benzodiazepines for severe anxiety.

Sources

Uchakina ON, et al. Immunomodulatory effects of selank in patients with anxiety-asthenic disorders. Bulletin of Experimental Biology and Medicine. 2008;145(4):495-497. doi:10.1007/s10517-008-0126-x
Zozulya AA, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorder (GAD). Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2008;108(4):38-48.
Volkova A, et al. Selank administration affects the expression of some genes involved in GABAergic neurotransmission. Frontiers in Pharmacology. 2016;7:31. doi:10.3389/fphar.2016.00031
Kozlovskii II, Danchev ND. The optimizing action of the synthetic peptide selank on a conditioned active avoidance reflex in rats. Neuroscience and Behavioral Physiology. 2003;33(7):639-643.
Kasian A, et al. GABA, selank, and olanzapine affect the expression of genes involved in GABAergic neurotransmission in IMR-32 cells. Frontiers in Pharmacology. 2017;8:89. doi:10.3389/fphar.2017.00089
Kolik LG, et al. Selank, peptide analogue of tuftsin, protects against ethanol-induced memory impairment by regulating of BDNF content in the hippocampus and prefrontal cortex in rats. Bulletin of Experimental Biology and Medicine. 2019;167(5):641-644. doi:10.1007/s10517-019-04589-2
Kost NV, et al. Mechanism of the anxiolytic effect of selank. Bulletin of Experimental Biology and Medicine. 2001;131(4):315-317. doi:10.1023/A:1017975332569
Medvedev VE, et al. The use of selank in the treatment of anxiety disorders. Zhurnal Nevrologii i Psikhiatrii. 2014;114(6):87-93.
Kozlovskaya MM, et al. The anxiolytic-like and nootropic effects of selank. Experimental and Clinical Pharmacology. 2003;66(1):5-8.
Filippenkov IB, et al. Effect of semax and its C-terminal peptide PGP on expression of neurotrophins and their receptors in rat brain during incomplete global ischemia. Molecular Biology. 2015;49(3):402-411. doi:10.1134/S0026893315020053